Literature DB >> 4016617

Acid neutralization capacity of Canadian antacid formulations.

M H Poleski.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 4016617      PMCID： PMC1346135     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Healing of duodenal ulcer with an antacid regimen.

Authors:  W L Peterson; R A Sturdevant; H D Frankl; C T Richardson; J I Isenberg; J D Elashoff; J Q Sones; R A Gross; R W McCallum; J S Fordtran
Journal:  N Engl J Med       Date:  1977-08-18       Impact factor: 91.245

2.  Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer.

Authors:  N Kumar; J C Vij; A Karol; B S Anand
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

3.  Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study.

Authors:  S K Lam; K C Lam; C L Lai; C K Yeung; L Y Yam; W S Wong
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

4.  Controlled clinical trial of duodenal ulcer healing with antacid tablets.

Authors:  A Berstad; A Rydning; E Aadland; B Kolstad; K Frislid; J Aaseth
Journal:  Scand J Gastroenterol       Date:  1982-10       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.